Anil K. Sood

发表

Rethinking ovarian cancer: recommendations for improving outcomes

Kenneth P. Nephew, James D. Brenton, Robert C. Bast, 2011, Nature Reviews Cancer.

RNA interference in the clinic: challenges and future directions

George A. Calin, Robert L. Coleman, Gabriel Lopez-Berestein, 2011, Nature Reviews Cancer.

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer

George A. Calin, Hui Ling, Priyabrata Mukherjee, 2016, Oncotarget.

Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients

A. Sood, D. Bodurka, C. Landen, 2007, Clinical Cancer Research.

Abstract A36: TP53 loss creates therapeutic vulnerability in colorectal cancer

Xiongbin Lu, Xiaoming He, Cristina Ivan, 2017 .

Advances and Challenges of Liposome Assisted Drug Delivery

Susan Hua, A. Sood, Lisa Sercombe, 2015, Front. Pharmacol..

Nanotechnology in cancer therapy

Bulent Ozpolat, Gabriel Lopez-Berestein, A. Sood, 2013, Journal of drug targeting.

Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery

Mauro Ferrari, Xuewu Liu, Haifa Shen, 2013, Clinical Cancer Research.

Molecular Pathways: Beta-Adrenergic Signaling in Cancer

Steven W. Cole, A. Sood, S. Cole, 2011, Clinical Cancer Research.

Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer

Michael Peyton, John D. Minna, Kakajan Komurov, 2013, Cell.

Genomic DNA Copy-Number Alterations of the let-7 Family in Human Cancers

Joel Greshock, Xiaowen Hu, Janos L. Tanyi, 2012, PloS one.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER

Paul C. Boutros, Mircea Ivan, Francesca M. Buffa, 2014, Nature Communications.

RNAi Therapies: Drugging the Undruggable

George A. Calin, Gabriel Lopez-Berestein, G. Calin, 2014, Science Translational Medicine.

Comprehensive epigenetic analysis of Notch pathway in high-grade serous ovarian cancer

Wei Hu, Cristina Ivan, Robert L. Coleman, 2013 .

Immune cell profiling in cancer: molecular approaches to cell-specific identification

Keith A. Baggerly, K. Baggerly, A. Sood, 2017, npj Precision Oncology.

Neuroendocrine influences on cancer progression

Steve W. Cole, A. Sood, S. Cole, 2013, Brain, Behavior, and Immunity.

A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis

Demin Li, Francesca M. Buffa, Roger Patient, 2013, Cancer cell.

Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma

Ilya Shmulevich, Yan Sun, Wei Zhang, 2012, PloS one.

Neuroendocrine modulation of cancer progression

Steve W. Cole, A. Sood, S. Cole, 2009, Brain, Behavior, and Immunity.

Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting

Xin Li, Mauro Ferrari, David G. Gorenstein, 2010, PloS one.

Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer

George A. Calin, Gabriel Lopez-Berestein, G. Calin, 2015, Non-coding RNA.

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Ilya Shmulevich, Wei Zhang, Matti Nykter, 2013, Cancer cell.

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

Soldano Ferrone, Liz Y. Han, A. Sood, 2008, Clinical Cancer Research.

Circular RNAs in Cancer

Sang Kook Lee, A. Sood, Sang Kook Lee, 2019, Molecular therapy. Nucleic acids.

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

Min Zhang, Prahlad T. Ram, Keith A. Baggerly, 2016, Nature Communications.